Distribution and roles of Ligilactobacillus murinus in hosts
Copyright © 2024 Elsevier GmbH. All rights reserved..
Ligilactobacillus murinus, a member of the Ligilactobacillus genus, holds significant potential as a probiotic. While research on Ligilactobacillus murinus has been relatively limited compared to well-studied probiotic lactic acid bacteria such as Limosilactobacillus reuteri and Lactobacillus gasseri, a mounting body of evidence highlights its extensive involvement in host intestinal metabolism and immune activities. Moreover, its abundance exhibits a close correlation with intestinal health. Notably, beyond the intestinal context, Ligilactobacillus murinus is gaining recognition for its contributions to metabolism and regulation in the oral cavity, lungs, and vagina. As such, Ligilactobacillus murinus emerges as a potential probiotic candidate with a pivotal role in supporting host well-being. This review delves into studies elucidating the multifaceted roles of Ligilactobacillus murinus. It also examines its medicinal potential and associated challenges, underscoring the imperative to delve deeper into unraveling the mechanisms of its actions and exploring its health applications.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:282 |
---|---|
Enthalten in: |
Microbiological research - 282(2024) vom: 15. März, Seite 127648 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chuandong, Zhou [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 18.03.2024 Date Revised 18.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.micres.2024.127648 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368575411 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368575411 | ||
003 | DE-627 | ||
005 | 20240318234346.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240218s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.micres.2024.127648 |2 doi | |
028 | 5 | 2 | |a pubmed24n1334.xml |
035 | |a (DE-627)NLM368575411 | ||
035 | |a (NLM)38367479 | ||
035 | |a (PII)S0944-5013(24)00049-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chuandong, Zhou |e verfasserin |4 aut | |
245 | 1 | 0 | |a Distribution and roles of Ligilactobacillus murinus in hosts |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.03.2024 | ||
500 | |a Date Revised 18.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier GmbH. All rights reserved. | ||
520 | |a Ligilactobacillus murinus, a member of the Ligilactobacillus genus, holds significant potential as a probiotic. While research on Ligilactobacillus murinus has been relatively limited compared to well-studied probiotic lactic acid bacteria such as Limosilactobacillus reuteri and Lactobacillus gasseri, a mounting body of evidence highlights its extensive involvement in host intestinal metabolism and immune activities. Moreover, its abundance exhibits a close correlation with intestinal health. Notably, beyond the intestinal context, Ligilactobacillus murinus is gaining recognition for its contributions to metabolism and regulation in the oral cavity, lungs, and vagina. As such, Ligilactobacillus murinus emerges as a potential probiotic candidate with a pivotal role in supporting host well-being. This review delves into studies elucidating the multifaceted roles of Ligilactobacillus murinus. It also examines its medicinal potential and associated challenges, underscoring the imperative to delve deeper into unraveling the mechanisms of its actions and exploring its health applications | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Lactobacillus | |
650 | 4 | |a Ligilactobacillus murinus | |
650 | 4 | |a Probiotic | |
700 | 1 | |a Hu, Jicong |e verfasserin |4 aut | |
700 | 1 | |a Li, Jiawen |e verfasserin |4 aut | |
700 | 1 | |a Wu, Yuting |e verfasserin |4 aut | |
700 | 1 | |a Wu, Chan |e verfasserin |4 aut | |
700 | 1 | |a Lai, Guanxi |e verfasserin |4 aut | |
700 | 1 | |a Shen, Han |e verfasserin |4 aut | |
700 | 1 | |a Wu, Fenglin |e verfasserin |4 aut | |
700 | 1 | |a Tao, Changli |e verfasserin |4 aut | |
700 | 1 | |a Liu, Song |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Wenfeng |e verfasserin |4 aut | |
700 | 1 | |a Shao, Hongwei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Microbiological research |d 1994 |g 282(2024) vom: 15. März, Seite 127648 |w (DE-627)NLM075034050 |x 1618-0623 |7 nnns |
773 | 1 | 8 | |g volume:282 |g year:2024 |g day:15 |g month:03 |g pages:127648 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.micres.2024.127648 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 282 |j 2024 |b 15 |c 03 |h 127648 |